HEPION PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)

Item 8.01 Other Events

On January 6, 2020, Hepion Pharmaceuticals, Inc. issued a press release announcing that the peer-reviewed journal, Expert Opinion on Investigational Drugs, has published a paper entitled, "Cyclophilin inhibition as a potential treatment for nonalcoholic steatohepatitis." A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits



  99.1     Hepion Pharmaceuticals, Inc. Press Release dated January 6, 2020

104      The cover page from this Current Report on Form 8-K, formatted in Inline
         XBRL.

© Edgar Online, source Glimpses